4//SEC Filing
Ziebell Mark R 4
Accession 0001683168-24-000242
CIK 0000704562other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:39 PM ET
Size
17.7 KB
Accession
0001683168-24-000242
Insider Transaction Report
Form 4
Ziebell Mark R
VP and General Counsel
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2024-01-09+1,250→ 64,615 total - Sale
Common Stock, $0.001 par value
2024-01-10$6.17/sh−1,346$8,305→ 63,269 total - Exercise/Conversion
Restricted Stock Units
2024-01-09−1,250→ 38,074 total→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2024-01-09+1,261→ 63,365 total - Exercise/Conversion
Restricted Stock Units
2024-01-09−1,261→ 39,324 total→ Common Stock (1,261 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2024-01-09+697→ 62,104 total - Exercise/Conversion
Restricted Stock Units
2024-01-09−697→ 40,585 total→ Common Stock (697 underlying)
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4, 5 and 6. This sale does not represent a discretionary trade by the reporting person.
- [F3]Represents a weighted average sales price per share. These shares were sold at prices ranging from $6.14 to $6.20. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
- [F5]RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
- [F6]RSUs granted to the reporting person on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001552642
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 7:39 PM ET
- Size
- 17.7 KB